Top 15 Diabetes Drugs in 2023 by 2022 Sales Statistics
XTalks
FEBRUARY 8, 2024
According to AstraZeneca, the drug had strong demand across all of its approved indications and was further supported by recent guideline updates from cardiology societies. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 This performance exceeded Wall Street’s expectations by 20 percent.
52 
Let's personalize your content